Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo Controlled Trial of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in High-risk Adults in the Critical Care Setting

NCT00520234 is registered in ClinicalTrials.gov with Mycoses Study Group as lead sponsor.

NCT NCT00520234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00520234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo Controlled Trial of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in High-risk Adults in the Critical Care Setting
Lead sponsor
Mycoses Study Group
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2007
Completion date
March 31, 2010
Enrollment
222 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

invasive candidiasis